Literature DB >> 11422398

Mitochondrial DNA deletion associated with the reduction of adenine nucleotides in human atrium and atrial fibrillation.

M Tsuboi1, I Hisatome, T Morisaki, M Tanaka, Y Tomikura, S Takeda, M Shimoyama, A Ohtahara, K Ogino, O Igawa, C Shigemasa, S Ohgi, E Nanba.   

Abstract

BACKGROUND: Structural changes in the number, size, and shape of mitochondria (mt) have been observed in the atrial muscles of patients with atrial fibrillation (AF) and of animals with rapid atrial pacing, however, it is not known whether the mitochondrial function is impaired in human atrium with AF.
MATERIALS AND METHODS: We determined adenine nucleotides concentrations and mtDNA deletions in 26 human right atria obtained at the time of cardiac surgery, using HPLC and PCR amplification, and studied the relationship between mtDNA deletions and clinical manifestations, the haemodynamic parameters of the patients and adenine nucleotide concentrations in their atrium.
RESULTS: The age and the prevalence of AF were significantly higher in the patients with a mtDNA deletion of 7.4 kb than in those without a deletion; there were no significant differences regarding haemodynamic parameters between the two groups. The concentrations of ATP, ADP, AMP and total adenine nucleotides in the right atrium were significantly lower in the patients with mtDNA deletions than the patients without a deletion. In a gender- and diseased-matched population, the mtDNA deletion was still significantly associated with age and a decreased concentration of adenine nucleotides in the atrium. Using quantitative PCR analysis, the proportion of mtDNA deletion to normal mtDNA of the atrium, was estimated to be 0.3-2% in four cases.
CONCLUSION: These results suggest that the deletion of mtDNA associated with ageing or AF can lead to a bioenergetic deficiency due to an impaired ATP synthesis in the human atrium; however, no conclusion can be made whether mtDNA deletion were the result or the cause of an impaired ATP synthesis, ageing, hemodynamic deterioration, or AF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422398     DOI: 10.1046/j.1365-2362.2001.00844.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  18 in total

1.  Compartmentation of energy metabolism in atrial myocardium of patients undergoing cardiac surgery.

Authors:  Evelin Seppet; Margus Eimre; Nadezhda Peet; Kalju Paju; Ehte Orlova; Mati Ress; Sirje Kõvask; Andres Piirsoo; Valdur A Saks; Frank N Gellerich; Stephan Zierz; Enn K Seppet
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

2.  Development of a novel proteomic approach for mitochondrial proteomics from cardiac tissue from patients with atrial fibrillation.

Authors:  Maryam Goudarzi; Mark M Ross; Weidong Zhou; Amy Van Meter; Jianghong Deng; Lisa M Martin; Chidima Martin; Lance Liotta; Emanuel Petricoin; Niv Ad
Journal:  J Proteome Res       Date:  2011-07-08       Impact factor: 4.466

3.  Rapid pacing of embryoid bodies impairs mitochondrial ATP synthesis by a calcium-dependent mechanism--a model of in vitro differentiated cardiomyocytes to study molecular effects of tachycardia.

Authors:  Lorenz Schild; Alicja Bukowska; Andreas Gardemann; Pamela Polczyk; Gerburg Keilhoff; Michael Täger; Samuel C Dudley; Helmut U Klein; Andreas Goette; Uwe Lendeckel
Journal:  Biochim Biophys Acta       Date:  2006-04-19

Review 4.  [Genetics of atrial fibrillation: rare mutations, common variants and clinical relevance?].

Authors:  M F Sinner; A Pfeufer; S Kääb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006-06

5.  Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway.

Authors:  Guang-Zhong Liu; Ting-Ting Hou; Yue Yuan; Peng-Zhou Hang; Jing-Jing Zhao; Li Sun; Guan-Qi Zhao; Jing Zhao; Jing-Mei Dong; Xiao-Bing Wang; Hang Shi; Yong-Wu Liu; Jing-Hua Zhou; Zeng-Xiang Dong; Yang Liu; Cheng-Chuang Zhan; Yue Li; Wei-Min Li
Journal:  Br J Pharmacol       Date:  2016-02-18       Impact factor: 8.739

6.  Selective downregulation of mitochondrial electron transport chain activity and increased oxidative stress in human atrial fibrillation.

Authors:  Larisa Emelyanova; Zain Ashary; Milanka Cosic; Ulugbek Negmadjanov; Gracious Ross; Farhan Rizvi; Susan Olet; David Kress; Jasbir Sra; A Jamil Tajik; Ekhson L Holmuhamedov; Yang Shi; Arshad Jahangir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

Review 7.  Impact of dietary fatty acids on cardiac arrhythmogenesis.

Authors:  Julie H Rennison; David R Van Wagoner
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-08

8.  Energetic metabolism during acute stretch-related atrial fibrillation.

Authors:  Jérôme Kalifa; Jean-Michel Maixent; Thierry Chalvidan; Christiane Dalmasso; David Colin; Dragos Cozma; Pierre Laurent; Jean-Claude Deharo; Pierre Djiane; Patrick Cozzone; Monique Bernard
Journal:  Mol Cell Biochem       Date:  2008-06-16       Impact factor: 3.396

9.  Decline of Phosphotransfer and Substrate Supply Metabolic Circuits Hinders ATP Cycling in Aging Myocardium.

Authors:  Emirhan Nemutlu; Anu Gupta; Song Zhang; Maria Viqar; Ekhson Holmuhamedov; Andre Terzic; Arshad Jahangir; Petras Dzeja
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

10.  Mitochondrial DNA 4977bp deletion mutation in peripheral blood reflects atrial remodeling in patients with non-valvular atrial fibrillation.

Authors:  Jihei Sara Lee; Young-Guk Ko; Kyoung-Jin Shin; Sook-Kyoung Kim; Jae Hyung Park; Ki-Cheol Hwang; Hui-Nam Pak
Journal:  Yonsei Med J       Date:  2015-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.